Ken Fisher acquired 60.2 Thousand Neurocrine Biosciences shares worth $7.95 Million. That's 0.00% of their equity portfolio (434th largest holding). The first Neurocrine Biosciences trade was made in Q3 2017. Since then Ken Fisher bought shares seven more times and sold shares on eighteen occasions. The stake costed the investor $5.22 Million, netting the investor a gain of 52% so far.